Novavax (NVAX) Operating Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Novavax (NVAX) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -2,649.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 30,461.00 |
| 10 | Novavax | 1.67 Bn | 950.86 Mn | 42.45 Mn | -10,991.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,991.00 |
| Mar 31, 2026 | 37,531.00 |
| Dec 31, 2025 | 7,791.00 |
| Sep 30, 2025 | -23,539.00 |
| Jun 30, 2025 | 30,201.00 |
| Mar 31, 2025 | 4,760.00 |
| Dec 31, 2024 | 22,284.00 |
| Sep 30, 2024 | 1,316.00 |
| Jun 30, 2024 | 15,479.00 |
| Mar 31, 2024 | -10,766.00 |
| Dec 31, 2023 | 238.00 |
| Sep 30, 2023 | 5,632.00 |
| Jun 30, 2023 | 6,098.00 |
| Mar 31, 2023 | 29,166.00 |
| Dec 31, 2022 | 25,736.00 |
| Sep 30, 2022 | 58,049.00 |
| Jun 30, 2022 | 83,246.00 |
| Mar 31, 2022 | 103,985.00 |
| Dec 31, 2021 | 38,786.00 |
| Sep 30, 2021 | 36,996.00 |